Research presented at this year’s annual meeting of the Radiological Society of North America shows the possible impact of social determinants of health (SDOH) on follow-up appointments for breast cancer. The findings demonstrate a possible link between risk for undiagnosed breast cancer and length of lapse in follow-up appointment.
“Diagnosing breast cancer at an early stage is very important for survival,” said Aaron Afran, a third-year medical student at Boston University School of Medicine (BUSM), in a statement. “Concerning mammography findings lead to the need for additional imaging, such as diagnostic mammography and ultrasound, and there can be a lapse in time between imaging appointments.”
Two groups of women who had breast imaging done at Bostom Medical Center (BMC) between January 2015 and December 2018 had their medical records retrospectively reviewed:
- Group 1 had 4959 women. They had a screening mammography and subsequently were recommended for diagnostic imaging. Their BI-RADS score was 0, the mean age was 59.1 years, and a majority (56.2%) were Black.
- Group 2 had 3028 women. They had diagnostic breast imaging and subsequently were recommended for biopsy. Their BI-RADS score was 4 or 5, the mean age was 60.9 years, and most (57.5%) were Black, as well.
For diagnostic imaging to biopsy, the longest lapses were seen with food (P < .001) and housing insecurity (P < .001), whereas having at least 1 SDOH (P < .001) or transportation issues (P = .0016) was linked with shorter lapses. Between screening mammography and diagnostic imaging, housing and food again exerted the most influence at extending the lapse, at P = .08 and P = .1405, respectively.
All of the women completed the BMC’s THRIVE screening tool, which addresses issues with education, employment, food, affording medications, housing, transportation, utilities, and caregiving. Close to one-third of the patients in both groups (group 1, 30.7%; group 2, 26.9%) had this complete data in their records, which covered from October 2017 to December 2018.
Afran posited that food and housing insecurity are simply more important priorities than imaging appointments among the patients studied.
“To best serve our patient population at a safety-net hospital, we must think creatively about the social factors that are preventing our patients from receiving the best care,” concluded Michael D. Fishman, MD, section chief of breast imaging at Boston Medical Center and the study’s senior author. “Our findings indicate longer lapses between diagnostic imaging and biopsy for patients with unmet social needs, which begs the question: are unmet social needs associated with some amount of breast cancer mortality that could have been prevented?”
Previous research mirrors their findings, reported Afran, in that the issue of later breast cancer stage at diagnosis has been shown to be influenced by poverty, lack of education, and social isolation.
Suggested areas of future study include analyzing the effects of these findings on survival and those of specific interventions.
Reference
Afran A, Donghoon S, LeBedis C, Fishman MDC. The impact of social determinants of health on breast imaging utilization. Presented at: RSNA 2020; November 29-December 5, 2020. https://press.rsna.org/pressrelease/2020_resources/2227/video_4.mp4
Social Determinants of Health May Influence Undiagnosed Breast Cancer Risk
Research presented at this year’s annual meeting of the Radiological Society of North America shows the possible impact of food or housing insecurity on follow-up appointments for breast cancer.
Research presented at this year’s annual meeting of the Radiological Society of North America shows the possible impact of social determinants of health (SDOH) on follow-up appointments for breast cancer. The findings demonstrate a possible link between risk for undiagnosed breast cancer and length of lapse in follow-up appointment.
“Diagnosing breast cancer at an early stage is very important for survival,” said Aaron Afran, a third-year medical student at Boston University School of Medicine (BUSM), in a statement. “Concerning mammography findings lead to the need for additional imaging, such as diagnostic mammography and ultrasound, and there can be a lapse in time between imaging appointments.”
Two groups of women who had breast imaging done at Bostom Medical Center (BMC) between January 2015 and December 2018 had their medical records retrospectively reviewed:
For diagnostic imaging to biopsy, the longest lapses were seen with food (P < .001) and housing insecurity (P < .001), whereas having at least 1 SDOH (P < .001) or transportation issues (P = .0016) was linked with shorter lapses. Between screening mammography and diagnostic imaging, housing and food again exerted the most influence at extending the lapse, at P = .08 and P = .1405, respectively.
All of the women completed the BMC’s THRIVE screening tool, which addresses issues with education, employment, food, affording medications, housing, transportation, utilities, and caregiving. Close to one-third of the patients in both groups (group 1, 30.7%; group 2, 26.9%) had this complete data in their records, which covered from October 2017 to December 2018.
Afran posited that food and housing insecurity are simply more important priorities than imaging appointments among the patients studied.
“To best serve our patient population at a safety-net hospital, we must think creatively about the social factors that are preventing our patients from receiving the best care,” concluded Michael D. Fishman, MD, section chief of breast imaging at Boston Medical Center and the study’s senior author. “Our findings indicate longer lapses between diagnostic imaging and biopsy for patients with unmet social needs, which begs the question: are unmet social needs associated with some amount of breast cancer mortality that could have been prevented?”
Previous research mirrors their findings, reported Afran, in that the issue of later breast cancer stage at diagnosis has been shown to be influenced by poverty, lack of education, and social isolation.
Suggested areas of future study include analyzing the effects of these findings on survival and those of specific interventions.
Reference
Afran A, Donghoon S, LeBedis C, Fishman MDC. The impact of social determinants of health on breast imaging utilization. Presented at: RSNA 2020; November 29-December 5, 2020. https://press.rsna.org/pressrelease/2020_resources/2227/video_4.mp4
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients
August 15th 2025The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Read More
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
July 15th 2025Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
Listen
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH
July 1st 2025Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.
Listen
Gallbladder Removal With 3-Plus Risk Factors May Increase MASLD Risk
August 13th 2025The risk of fatty liver disease is especially high in patients with multiple cardiometabolic risk factors who undergo gallbladder removal, according to research from South Korea.
Read More
Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer
August 13th 2025High-volume cancer centers utilizing neoadjuvant chemotherapy (NACT) significantly reduce surgical mortality and enhance survival rates in patients with advanced ovarian cancer.
Read More
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients
August 15th 2025The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Read More
Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD
July 15th 2025Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
Listen
PCPs Have Unique Opportunity to Detect, Manage CKD
August 14th 2025As the prevalence of chronic kidney disease (CKD) continues to rise, empowering primary care providers (PCPs) with the tools, training, and collaborative frameworks needed for optimal management is a public health priority, emphasize the researchers.
Read More
Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH
July 1st 2025Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.
Listen
Gallbladder Removal With 3-Plus Risk Factors May Increase MASLD Risk
August 13th 2025The risk of fatty liver disease is especially high in patients with multiple cardiometabolic risk factors who undergo gallbladder removal, according to research from South Korea.
Read More
Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer
August 13th 2025High-volume cancer centers utilizing neoadjuvant chemotherapy (NACT) significantly reduce surgical mortality and enhance survival rates in patients with advanced ovarian cancer.
Read More